Evaluation of Colorado oncology providers on the use of medical marijuana.

Authors

Ashley Glode

Ashley Elizabeth Glode

Univsersity of Colorado, Aurora, CO

Ashley Elizabeth Glode , Garth C. Wright , Stephen Leong

Organizations

Univsersity of Colorado, Aurora, CO, University of Colorado, Aurora, CO, University of Colorado Comprehensive Cancer Center, Aurora, CO

Research Funding

Other

Background: There is a lack of knowledge regarding medical marijuana use in cancer patients. More information is needed due to increase in both state approvals and access to medical marijuana. We hypothesized that variation in provider knowledge, attitudes, and behaviors exists across all professions in oncology, which contributes to a lack of both provider awareness of patient use and patient education on marijuana use. Methods: A survey was distributed to oncology providers in the state of Colorado. The primary objective was to describe provider knowledge, attitudes, and behaviors regarding medical marijuana use in cancer patients. Other objectives were identifying educational needs for oncology providers to feel comfortable recommending medical marijuana and reporting provider interest in future marijuana studies. Results: We received responses from 172 oncology providers; 48 advanced practice providers, 47 physicians, 53 registered nurses, 17 pharmacists, and 7 other. Most providers (73.3%) believe marijuana provides a medical benefit to cancer patients, and 81.5% believe it should be available as a prescription drug. Yet, 60.1% had not recommend its use to any cancer patient in the past 6 months, and 54.3% are not comfortable recommending or suggesting it to a patient to manage cancer related symptoms. Major concerns included uncertain dosing (83%), limited knowledge of available products and where to get them (73.1%), and interactions with other medications (64.9%). Providers reported that educational programs for healthcare providers (79.3%), more clinical data (74%), and endorsed clinical guidelines (67.5%) would increase their comfort level in recommending medical marijuana. The areas of research most interesting or important were specific product information and doses (77.6%), efficacy for specific side effects (77.6%), and drug-drug interactions (74.7%). Conclusions: Regardless of profession, the majority of oncology providers in Colorado do not recommend and do not feel comfortable recommending or suggesting medical marijuana to a cancer patient, yet most believe it provides medical benefit. Providers believe there is a need for education and research on the use of medical marijuana in oncology patients.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Education Research and Professional Development

Track

Medical Education and Professional Development

Sub Track

Education Research

Citation

J Clin Oncol 37, 2019 (suppl; abstr 10511)

DOI

10.1200/JCO.2019.37.15_suppl.10511

Abstract #

10511

Poster Bd #

90

Abstract Disclosures

Similar Abstracts

Abstract

2023 ASCO Annual Meeting

Cannabis use among recently treated cancer patients: Perceptions and experiences.

First Author: Talya Salz

Abstract

2024 ASCO Quality Care Symposium

Prescribing comfort: Understanding pain medication prescribing patterns in cancer care.

First Author: Jennifer Fernandez

First Author: Safiya Karim

Abstract

2022 ASCO Quality Care Symposium

A novel cannabis education clinic for patients with cancer: Patient characteristics from initial visit.

First Author: Dylan M. Zylla